Phase II Study of Erdafitinib in Patients With Tumors With <i>FGFR</i> Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1Jun Gong, Keith T. Flaherty, Edith P. Mitchell et al.|JCO Precision Oncology|2024Cited by 16
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical TrialsJia Liu, Anthony M. Joshua, Lesley Seymour et al.|Journal of Clinical Oncology|2025Cited by 11